Navigation Links
Golden Meditech Pioneers into China's Hospital Market
Date:6/24/2008

HONG KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- The Board of Directors of Golden Meditech Company Limited (the "Company"; stock code: 8180.HK) is pleased to announce today that the Company has made significant progress in entering China's hospital management market through the acquisition of Topshine Hospital Management (China) Company Limited and Daopei Hospitals Group, the largest private haematologist hospitals with presence in Beijing and Shanghai in China. Upon completion, the company will become the first foreign institution in China granted with a license to manage and provide nationwide management consultancy to hospitals in China.

Pursuant to the terms of the agreement, Golden Meditech will acquire 70% of contributor's interests in the Daopei Hospitals Group and 60% equity interests in Topshine Hospital Management Company (China) Limited for an aggregate cash consideration of HK$830 million.

Once the proposed transaction is completed, Golden Meditech will obtain the rights to manage hospitals nationwide. This marks the first time for a foreign institution to offer nationwide hospital management consultancy in China.

Mr. KAM Yuen, Chairman of Golden Meditech, explains that acquiring the Daopei Hospitals, the largest and most renowned hematologist hospital in China, represents a significant move by the company to optimize its business structures and strengthen its presence in China's healthcare industry. Tremendous synergies will be created with the Company's existing businesses especially in the areas of healthcare services, cord blood stem cells clinical applications and manufacture and sales of medical devices.

Mr. KAM Yuen points out through this acquisition, Golden Meditech will not only gain the opportunity to enter into the high-threshold hospital management industry, but also inherit experienced and seasoned medical staff and management teams, in addition to generating stable earnings. In future, the Company plans to expand the professional hospital management operations in areas of haematologies, tumor and pediatrics through its existing hospital network in a bid to become the largest professional hospital management group in China.

Background Information:

China's Hospital Services Market:

According to statistics, in 2007, China's healthcare services expenditures accounted for less than 5% of the country's GDP (gross domestic product), which is far behind 15% of USA during the same period. In addition, benefiting from the country's booming economy, increase in government healthcare spending to extend the coverage of basic social medical insurance, the improvement in general living standards, and people becoming more health- conscious and expecting higher healthcare services standards, all these factors are believed to lead China's healthcare services industry into golden era period.

However, at present, more than 90% of hospitals in China are state-owned nationwide, and less than 10% are owned by non-state-owned entities. This ratio of 10% is far lower compared with that of most Asian countries, whereas private hospitals account for almost 50% of the market shares. This means that China hospital market has a great market potential for future expansion.

Topshine China: Topshine Hospital Management (China) Company Limited is established by the management team of Daopei and it is the first foreign company allowed to provide nationwide hospital management services in China.

Daopei Hospitals: Headquartered in Beijing with a Shanghai branch, the Daopei hospitals have over 200 hospital beds in Beijing and Shanghai, and the largest number of laminar air-flow wards in Asia.

As a leading specialist hospital for diagnosis and treatment of blood- related diseases and malignant tumors, Daopei Hospitals are renowned to conduct sibling allogeneic cord blood stem cell transplantation, unrelated cord blood stem cell transplantation, umbilical cord blood stem cell transplantation, mismatched haploidentical transplantation, syngenic (twins) transplantation and autologous transplantation. During the past six years, Daopei Hospitals conducted about 690 cases of allergenic cord blood stem cell transplantation with successful implantation rate of 99.67% and overall survival rate of 70%, reaching an international level. The hospitals' reputation attracts numerous domestic and overseas leukaemia patients every year, and currently, their utilization rates of hospital beds exceed 100%.

Mr. LU Dao Pei, founder of the Daopei Hospitals, is a renowned haematologist and the so-called "Father of Bone Marrow Transplant "in China, an elected member of the Chinese Academy of Engineering (Division of Medicine and Health), a committee member of the Academic Committee of Peking University Health Science Center, and the Chief Expert for Haematology, National Key Disciplines in Peking University.

The Beijing and Shanghai Daopei Hospital are few privately-run hospitals, covered by the country's basic medical insurance scheme. In addition, Daopei Hospitals are also the only private specialist hospital endorsed to perform blood stem cell transplants.

Golden Meditech: Founded in 2000 and listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited in December 2001, Golden Meditech is the first hi-tech medical device enterprise that went public outside of the PRC. During the past few years, thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing the emerging market opportunities, Golden Meditech's medical device, cord blood banking services and natural herbal medicine have all established dominant positions in each of the segments that the company engages in. Going forward, Golden Meditech will continue its pursuit of becoming China's leading integrated medical group through organic growth, acquisition and strategic investment.

For inquiry, please kindly contact the Investor Relations Division, Golden Meditech Company Limited.

Contact:

Dennis Haikuan Lu

Investor Relations Manager

Golden Meditech Company Limited (8180.HK)

Tel: +852-3605-8138

Fax: +852-3605-8181

Email: ir@goldenmeditech.com


'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Corrals Good Health Recipe for the Flu Season
2. National Energy Services Receives Repeat Orders From Golden Living and Cathedral Rock Skilled Nursing Facilities
3. Giving Back to the Community Golden Corral Style
4. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association
5. Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity
6. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
7. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop Drive-Through Mastectomies
8. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
9. American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony
10. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
11. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: